Upgrade to SI Premium - Free Trial

Ionis Pharma (IONS) Misses Q1 EPS by 2c

May 9, 2017 7:18 AM

Ionis Pharma (NASDAQ: IONS) reported Q1 EPS of $0.03, $0.02 worse than the analyst estimate of $0.05. Revenue for the quarter came in at $110.3 million versus the consensus estimate of $116.45 million.

For earnings history and earnings-related data on Ionis Pharma (IONS) click here.

Categories

Earnings Guidance

Next Articles